I think the frustration is when we hear there is n
Post# of 155256
(Total Views: 594)
Posted On: 09/22/2020 9:34:56 PM
I think the frustration is when we hear there is no money to do trials at sufficient N, which would accelerate the path to $B's and then you hear they are turning down offers of $40M in investment (which could do the trials). If you need large N to get approval, thats then your goal. period.
Also, would it not be better to focus on less trials until you get the cash flow going or raise at a higher price due to BLA or covid approval ?
I you have cure for covid (JL's words) - and I do believe they do for the majority of people (no drug is perfect). Why would you not put all your money and resources there, and raise the money to get the share price to $20+ and then do the rest faster also at that point?
Also - don't stop the CD12 - you need that largest N as possible (in fact you may need a bigger number).
Also, would it not be better to focus on less trials until you get the cash flow going or raise at a higher price due to BLA or covid approval ?
I you have cure for covid (JL's words) - and I do believe they do for the majority of people (no drug is perfect). Why would you not put all your money and resources there, and raise the money to get the share price to $20+ and then do the rest faster also at that point?
Also - don't stop the CD12 - you need that largest N as possible (in fact you may need a bigger number).
(2)
(0)